Fortress Biotech
FBIO
50 hedge funds and large institutions have $20.9M invested in Fortress Biotech in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $21.8M → $20.9M (-$959K)
4% less funds holding
Funds holding: 52 → 50 (-2)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
23% less call options, than puts
Call options by funds: $356K | Put options by funds: $464K
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$109K |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$85.1K |
| 3 |
State Street
Boston,
Massachusetts
|
+$82.5K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$68.9K |
| 5 |
Morgan Stanley
New York
|
+$43.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$1.69M |
| 2 |
Goldman Sachs
New York
|
-$710K |
| 3 |
RA
Royce & Associates
New York
|
-$397K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$135K |
| 5 |
Bank of New York Mellon
New York
|
-$58.4K |
FBIO Hedge Fund Activity: Q3 2016 in Review
50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2016, worth a combined $20.9M — down 4.4% from $21.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FBIO and 4 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 14 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $109K. The largest seller was Elliott Management, cutting an estimated $1.69M.
- 50 institutional investors held Fortress Biotech (FBIO) as of Q3 2016, down from 52 in Q2 2016.
- Funds reported $20.9M of Fortress Biotech stock for Q3 2016, down 4.4% quarter-over-quarter.
- 4 funds opened new Fortress Biotech positions in Q3 2016 and 6 closed out, a net change of -2 holders.
- The largest Fortress Biotech buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $109K added.
- The largest Fortress Biotech seller in Q3 2016 was Elliott Management, an estimated $1.69M sold.
Based on aggregated 13F filings for Q3 2016.